Intravesical Bacillus Calmette Market Expands with Cancer Care
The global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and long-term disease management. Growing awareness regarding … Read more